The Commission determined that a five-stage medicinal cannabis (CBD/THC) treatment program of four months' duration was reasonably necessary treatment under s 60 of the Workers Compensation Act 1987 for a worker with chronic right foot and bilateral hip pain, insomnia, and anxiety arising from a workplace injury. On the facts, the Commission found the treatment satisfied the causation and reasonable necessity requirements notwithstanding the worker's pre-injury history of cannabis use and a single episode of diagnosed psychosis, holding that the proposed treatment would be sufficiently monitored by the treating specialist and his team to manage any psychiatric risks. The absence of any competing medico-legal evidence from the respondent was a significant factor, as the respondent relied solely on the applicant's own forensic expert's qualified reservations about safety.
The full text is available to signed-in members.